Expert consensus on repeated low-level red-light as an alternative treatment for childhood myopia (2022)

Author: Expert workgroup of expert consensus on repeated low-level red-light as an alternative treatment for childhood myopia (2022)
DOI: 10.3760/cma.j.cn115989-20220616-00279
Published 2022-07-10
Cite asChin J Exp Ophthalmol, 2022, 40(7): 599-603.

Abstract

Repeated low-level red-light (RLRL) therapy has been adopted into research and practice on childhood myopia control nationwide.Preliminary clinical evidence showed that RLRL has some effect on slowing myopia progression.However, sub-optimal applications could become a challenge, including increase in risk of potential adverse reactions, due to a lack of consolidated standards.Accordingly, based on current evidence and expert consensus, presented as eight aspects including basic mechanism, eligibility, procedures and dosage, clinical examinations, device and power specification, adverse reactions, use termination and combined use with other treatments, this Expert consensus on repeated low-level red-light therapy as an alternative treatment of childhood myopia (2022) was developed, with an aim to standardize this new clinical procedure.

Key words:

Myopia; Alternative treatment; Repeated low-level red-light; Children; Adolescents; Consensus

Contributor Information

Expert workgroup of expert consensus on repeated low-level red-light as an alternative treatment for childhood myopia (2022)
(Read 13 times, 1 visits today)